NYSE Consumer good sector gainers: (BZ, AXL, WNC, LIZ, XRX)


NYSE Consumer good sector gainers: (BZ, AXL, WNC, LIZ, XRX)

Boise Inc. (NYSE: BZ) surged by 2.92% and closed at $5.99 with overall traded volume of 1.42 million shares. Its PE ratio stood at 3.57. Boise Inc. is a manufacturer of packaging products and papers, including corrugated containers, containerboard, label and release and flexible packaging papers, imaging papers for the office and home, printing and converting papers, newsprint, and market pulp. The Company owns pulp and paper mill operations in Jackson, Alabama; International Falls, Minnesota; St. Helens, Oregon, and Wallula, Washington, all of which manufacture uncoated freesheet paper. The Company also owns a mill in DeRidder, Louisiana, which produces containerboard (linerboard) and newsprint. In addition, it has a network of five corrugated container plants located in the Pacific Northwest, a corrugated sheet plant in Nevada and a corrugated sheet feeder plant in Texas. The Company operates its business in three segments:  Paper, Packaging, and Corporate and Other (support services).

American Axle & Manufact. Holdings, Inc. (NYSE: AXL) closed at $9.31 after jumping up by 2.31% whereas total traded volume stood at 6.48 million shares. Its total market capitalization arrived at $665.11 million for the day. American Axle & Manufacturing Holdings Inc. (AAM) manufactures, engineers, designs and validates driveline and drivetrain systems and related components and chassis modules for light trucks, sport utility vehicles (SUVs), passenger cars, crossover vehicles and commercial vehicles. Driveline and drive train systems include components that transfer power from the transmission and deliver it to the drive wheels. The driveline, drivetrain and related products include axles, chassis modules, driveshafts, power transfer units, transfer cases, chassis and steering components, driveheads, crankshafts, transmission parts and metal-formed products.

Wabash National Corporation (NYSE: WNC) went up by 2.20% to close at $8.37 with traded volume of 992,058 shares. WNC’s total market capitalization ended at $260.22 million shares in the last trading session. Wabash National Corporation (Wabash) is engaged in designing, manufacturing and marketing standard and customized truck trailers and related transportation equipment. Through its subsidiary, Transcraft Corporation Wabash also manufactures steel flatbed and dropdeck trailers. It markets the transportation equipment under the Wabash, DuraPlate, DuraPlateHD, FreightPro, ArcticLite, RoadRailer, Transcraft, Eagle, Eagle II, D-Eagle and Benson trademarks directly to customers, through independent dealers and through the Company-owned retail branch network.

Liz Claiborne, Inc. (NYSE: LIZ)closed at $4.74 after gaining by 1.28% whereas overall traded volume of 1.16 million shares. Its total market capitalization arrived at $447.93 million. Liz Claiborne, Inc., incorporated in January 1976, designs and markets a global portfolio of retail-based brands, including JUICY COUTURE, KATE SPADE, LUCKY BRAND and MEXX. The Company also has a group of department store-based brands with consumer franchises, including the LIZ CLAIBORNE and MONET families of brands, MAC & JAC, KENSIE and DANA BUCHMAN and the licensed DKNY JEANS, DKNY ACTIVE and DKNY MENS brands.

Xerox Corporation (NYSE: XRX) reported the gain of 1.14% to close at $9.74 with total traded volume of 19.70 million shares. Its price to earnings ratio stood at 21.17 in the last trading session. Xerox Corporation (Xerox) provides a portfolio of document systems and services for businesses of any size. This includes printers, multifunction devices, production publishing systems, managed print services (MPS) and related software. The Company also offers support and supplies, such as toner, paper and ink as part of its document technology offerings. It operates in three segments:  Production, Office and Other. During the year ended December 2009, Global Imaging Systems, Inc. (GIS) acquired ComDoc, Inc. In February 2010, it acquired Affiliated Computer Services, Inc. (ACS). ACS is a provider of business process outsourcing, and information technology services and solutions to commercial and government clients worldwide in areas that include finance and accounting services, communications, transportation, human resources, healthcare, transaction processing, and customer care.




Delta Petroleum Corp. (NASDAQ: DPTR) surged by 9.25% and closed at $0.87 whereas overall traded volume stood at 8.88 million shares. Delta Petroleum Corporation (Delta) is an independent oil and gas company engaged primarily in the exploration for, and the acquisition, development, production, and sale of, natural gas and crude oil. Delta operated in two business segments:  acquisition, exploration, development, and production of oil and natural gas properties and related business activities, and contract oil and natural gas drilling operations. The primary areas of activity are in the Rocky Mountain and Gulf Coast Regions with additional unproved exploratory leaseholds in the Columbia River Basin in southeastern Washington, the Hingeline area of Central Utah, and the Haynesville Shale area of Texas, among others. Total oil and gas leasehold is approximately 813,000 acres.

Star Scientific, Inc. (NASDAQ: CIGX) closed at $2.13 after moving up by 14.52% with total traded volume of 8.42 million shares in the last trading day. Star Scientific, Inc. (Star Scientific) is engaged in the development of very low-tobacco-specific nitrosamines (TSNA), non-fermented smokeless tobacco products. The Company is also engaged in the development, implementation and licensing of its technology for the curing of tobacco so as to prevent the formation of carcinogenic toxins present in tobacco and tobacco smoke, primarily the TSNAs and manufactures, sells, markets and/or develop very low-TSNA dissolvable smokeless tobacco products, including ARIVA compressed powdered tobacco cigalett pieces and STONEWALL Hard Snuff and modified risk tobacco products. It is also engaged in the development of pharmaceutical products, particularly products that have a botanical, tobacco-based component, that are designed to treat tobacco dependence and a range of neurological conditions, including Alzheimer’s disease, Parkinson’s disease, schizophrenia and depression, and is also in the development of non-nicotine nutraceutical products.

RF Micro Devices, Inc. (NASDAQ: RFMD) jumped up 6.15% to close at $4.49 whereas overall traded volume stood at 7.79 million shares for the day.

Pacific Ethanol Inc (NASDAQ: PEIX) closed at $0.54 after increasing by 22.17% with traded volume of 5.80 million shares in the last trading session. Pacific Ethanol, Inc. is a marketer and producer of low carbon renewable fuels in the Western United States. It produces and sells ethanol and its co-products, including wet distillers grain and provides transportation, storage and delivery of ethanol through third-party service providers in the Western United States, primarily in California, Nevada, Arizona, Oregon, Colorado, Idaho and Washington. On May 17, 2009, five of its indirect wholly owned subsidiaries, Pacific Ethanol Holding Co. LLC, Pacific Ethanol Madera LLC, Pacific Ethanol Columbia, LLC, Pacific Ethanol Stockton, LLC and Pacific Ethanol Magic Valley, LLC, each commenced a case by filing voluntary petitions for relief under the Bankruptcy Code in the United States Bankruptcy Court for the District of Delaware in an effort to restructure their indebtedness. In June 2010, Pacific Ethanol Inc. announced the emergence from bankruptcy of Pacific Ethanol Holding Co. LLC (PEH) and its four wholly owned subsidiaries.

Melco Crown Entertainment Ltd (NASDAQ: MPEL) reported the gain of 3.89% and closed at $4.27 with overall traded volume of 5.72 million shares in the last trading day. Melco Crown Entertainment Limited (MPEL) is a developer, owner and, through its subsidiary Melco Crown Gaming, operator of casino gaming and entertainment resort facilities focused on the Macau market. Melco Crown Gaming is one of the six companies licensed, through concessions or sub-concessions, to operate casinos in Macau. The Company owns and operates City of Dreams, Altira Macau, Mocha Clubs and Taipa Square Casino. Its other projects include City of Dreams Phase II, Macau Studio City Project and Macau Peninsula Site.

Two Hot Company’s Looking To Save Lives On Two Different Standards: PWRM, PIP

Power3 Medical Products, Inc. (OTCBB: PWRM)

Stem Cells have the remarkable potential to develop into many different cell types during early life and growth. In addition, in many tissues they serve as an internal repair system, dividing essentially without limit to replenish other cells.

When a stem cell divides, each new cell has the potential either to remain a stem cell or become another type of cell with a more specialized function, such as a muscle cell, a red blood cell, or a brain cell.

The latter is where Alzheimer’s research comes into play.

Stage I clinical trials are about to begin using Adult Stem Cells to hopefully cure Alzheimer’s disease.

The first phase of a clinical development program is designed to assess safety, determine a dose range and identify potential side effects

Using (OTCBB: PWRM)’s Biomarkers to identify Alzheimer’s, allows the early stage detection, and early detection means more options.

(OTCBB: PWRM), is right in the fold of this potential cure, as their protein biomarker will allow for the earliest detection.

Early detection is very relevant to cure. And (OTCBB: PWRM) is in the forefront of this fight.

We have (OTCBB: PWRM) on our radar it should also be on yours.

PharmAthene, Inc. (NYSE Amex: PIP)

(NYSE Amex: PIP) a biodefense company specializing in the development and commercialization of medical countermeasures against chemical and biological threats, has recently annoucned that the Company will present at the Noble Financial Sixth Annual Equity Conference ‘ONTRACK 2010′ on Monday, June 7, 2010 at 4:00 p.m. ET in Room 3 – Piquet. The Company’s presentation will be available via webcast under the Investor Relations section at the Company’s website at: www.PharmAthene.com.

PharmAthene was formed to meet the critical needs of the United States and its allies by developing and commercializing medical countermeasures against biological and chemical weapons. PharmAthene’

s lead product development programs include:

* SparVax™ – a second generation recombinant protective antigen (rPA) anthrax vaccine
* Third generation rPA anthrax vaccine
* Valortim® – a fully human monoclonal antibody for the prevention and treatment of anthrax infection
* Protexia® – a novel bioscavenger for the prevention and treatment of morbidity and mortality associated with exposure to chemical nerve agents

For more information about PharmAthene, please visit www.PharmAthene.com.

BioMedical Stock Report from PennyGovernance.com. PWRM.OB, ACTG, ACOR, PDLI


Power3 Medical’s (OTCBB: PWRM.OB) business focus is the development of commercial applications for their proprietary technologies. The scientific team is on the leading edge of the proteomics industry through their discovery of protein footprints, pathways, and mechanisms of disease. These discoveries are being used to develop screening and diagnostic tests for the early detection and treatment of disease. The protein biomarkers, drug targets, and diagnostic tests are targeted toward markets with critical unmet needs in areas such as breast cancer, neurodegenerative disease and drug resistance in cancer. The Company is in a strong competitive position with over 190 identified biomarkers and a state-of-the-art proteomics laboratory.

PWRM pursues an aggressive intellectual property strategy to protect its inventions and discoveries made on its own and with its collaborators. Power3 Medical works with key physician scientists at major medical research and treatment centers. With access to decisive human clinical samples and superior trade secret proteomic methodologies, the Company provides solutions to pressing challenges in diagnosis and treatment of patients and has concluded research agreements, technology license agreements, and filed provisional and utility patents.

Acacia Research Corporation (Nasdaq: ACTG) announced today that its subsidiary, Telematics Corporation, has entered into a patent license agreement with Navman Wireless Holdings LP.

Telematics’ patented technology generally relates to systems and methods for displaying mobile vehicle information on a map. This technology can be used in navigation and fleet management systems that combine wireless communication with GPS tracking and map displays.

Acacia Research’s subsidiaries partner with inventors and patent owners, license the patents to corporate users, and share the revenue. Acacia Research’s subsidiaries control over 150 patent portfolios, covering technologies used in a wide variety of industries.

Acorda Therapeutics, Inc. (Nasdaq: ACOR) recently announced that Ron Cohen, M.D., President and Chief Executive Officer, is the recipient of the New York Biotechnology Association (NYBA) “The Cures Start Here” Business Leader of the Year Award. The award is presented for outstanding service to the patient community and to NYBA.

“Under Dr. Cohen’s leadership, Acorda recently received FDA approval for AMPYRA™, which represents a significant contribution to the treatment of people with multiple sclerosis,” said Nathan Tinker, Ph.D., Executive Director of NYBA. “Acorda exemplifies the vibrancy of the New York biotechnology industry and NYBA is pleased to recognize Dr. Cohen for his dedication to helping people with neurological disease, and for his ongoing commitment to the growth of the biotechnology industry in New York.”

PDL BioPharma, Inc. (Nasdaq:PDLI) recenlty announced revenue guidance for the second quarter ended June 30, 2010 of approximately $120 million, as compared with actual results of $125.9 million for the second quarter of 2009. Included in second quarter 2010 guidance is $1.5 million earned on Eurodollar foreign currency hedging contracts that the Company initiated in January 2010. Included in actual results for the second quarter 2009 and not included in second quarter 2010 guidance are the second of two $12.5 million installment payments from Alexion and royalties of $18.9 million for sales of Synagis®. The Company does not anticipate receiving royalties for Synagis sales in the second quarter of 2010 due to the ongoing legal dispute with MedImmune.